Reported Aug 9, 2023 · Terminated

neostigmine 5 mg/5mL (1mg/mL) Syringe, Rx only, This drug was repacked by CAPS, Inc., 2200 South 43rd Avenue, Pheonix,…

Central Admixture Pharmacy Services, Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Central Admixture Pharmacy Services, Inc. · 2200 S 43rd Ave · Phoenix, AZ · 85043-3909

neostigmine 5 mg/5mL (1mg/mL) Syringe, Rx only, This drug was repacked by CAPS, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043
NDC72196-6065-1

Lot codes and dates: Lot
36-239285
36-239287
Exp. 7/11/2023
36-239456
Exp. 7/12/2023
36-239873
Exp. 7/13/2023
36-240994
36-240995
36-240996
36-240997
Exp. 7/18/2023
36-241447
Exp. 7/20/2023
36-242407
36-242408
Exp. 7/25/2023
36-246298
Exp. 8/3/2023
36-248998
Exp. 8/16/2023
36-251613
Exp. 8/28/2023
36-251781
Exp. 8/29/2023
Amount recalled: 6,468 Syringes

The agency filed one notice per product. You are reading one of them; the other 94 are below.

82 more are in the archive.

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

This product could cause temporary or reversible health problems — stop using it.

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.